Search

Your search keyword '"Heparitin Sulfate analysis"' showing total 722 results

Search Constraints

Start Over You searched for: Descriptor "Heparitin Sulfate analysis" Remove constraint Descriptor: "Heparitin Sulfate analysis" Database MEDLINE Remove constraint Database: MEDLINE
722 results on '"Heparitin Sulfate analysis"'

Search Results

1. Human induced pluripotent stem cells are resistant to human cytomegalovirus infection primarily at the attachment level due to the reduced expression of cell-surface heparan sulfate.

2. Development of an Analytical Method for Unsaturated Disaccharides from Heparan Sulfate Using Dansylhydrazine Derivatization and High-Performance Liquid Chromatography with Fluorescence Detection.

3. High sensitivity (zeptomole) detection of BODIPY-labelled heparan sulfate (HS) disaccharides by ion-paired RP-HPLC and LIF detection enables analysis of HS from mosquito midguts.

4. Simultaneous determination of heparan sulfate, chondroitin/dermatan sulfates, and hyaluronan glycosaminoglycan disaccharides by high-performance liquid chromatography using a reverse-phase column with adamantyl groups.

5. Construction of mouse cochlin mutants with different GAG-binding specificities and their use for immunohistochemistry.

6. Glycosaminoglycan Analysis: Purification, Structural Profiling, and GAG-Protein Interactions.

7. Adherence of Candida albicans and Malassezia Species to Skin Cells Induces Changes in the Expression of Genes Responsible for Heparan and Chondroitin Sulfate Chain Synthesis.

8. External quality assessment in the absence of proficiency testing: A split-sample testing program experience.

9. Characterization of Glycosaminoglycan Disaccharide Composition in Astrocyte Primary Cultures and the Cortex of Neonatal Rats.

10. Structural analysis of glycosaminoglycans from Oviductus ranae.

11. Effect of Hydroxyethyl Starch Loading on Glycocalyx Shedding and Cerebral Metabolism During Surgery.

12. Salt and solvent effects in the microscale chromatographic separation of heparan sulfate disaccharides.

13. Sequencing Heparan Sulfate Using HILIC LC-NETD-MS/MS.

14. Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation.

15. Analysis of Heparan sulfate/heparin from Colla corii asini by liquid chromatography-electrospray ion trap mass spectrometry.

16. Glycosaminoglycans compositional analysis of Urodele axolotl (Ambystoma mexicanum) and Porcine Retina.

17. Negative-Ion Mode Capillary Isoelectric Focusing Mass Spectrometry for Charge-Based Separation of Acidic Oligosaccharides.

18. Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas.

19. The exostosin family of glycosyltransferases: mRNA expression profiles and heparan sulphate structure in human breast carcinoma cell lines.

20. Glycosaminoglycanomic profiling of human milk in different stages of lactation by liquid chromatography-tandem mass spectrometry.

21. Negative Electron Transfer Dissociation Sequencing of 3-O-Sulfation-Containing Heparan Sulfate Oligosaccharides.

22. Heparin/heparan sulfate analysis by covalently modified reverse polarity capillary zone electrophoresis-mass spectrometry.

23. Sensitive method for glycosaminoglycan analysis of tissue sections.

24. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.

25. Reduction in Brain Heparan Sulfate with Systemic Administration of an IgG Trojan Horse-Sulfamidase Fusion Protein in the Mucopolysaccharidosis Type IIIA Mouse.

26. One-pot analysis of sulfated glycosaminoglycans.

27. Glycosaminoglycans from bovine eye vitreous humour and interaction with collagen type II.

28. Glycosaminoglycans from fish swim bladder: isolation, structural characterization and bioactive potential.

29. Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection.

30. Concentration of sulfated glycosaminoglycans in the mammary tissue of female rats with the aging and about hormonal influence.

31. Analysis of procainamide-derivatised heparan sulphate disaccharides in biological samples using hydrophilic interaction liquid chromatography mass spectrometry.

32. Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling.

33. Glycocalyx Degradation after Pulmonary Transplantation Surgery.

34. Versatile Separation and Analysis of Heparan Sulfate Oligosaccharides Using Graphitized Carbon Liquid Chromatography and Electrospray Mass Spectrometry.

35. Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.

36. Heparan sulfate disaccharide measurement from biological samples using pre-column derivatization, UPLC-MS and single ion monitoring.

37. Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical Approach.

38. A Multivariate Mixture Model to Estimate the Accuracy of Glycosaminoglycan Identifications Made by Tandem Mass Spectrometry (MS/MS) and Database Search.

39. Glycosaminoglycans from chicken muscular stomach or gizzard.

40. Heparan Sulfate and Chondroitin Sulfate Glycosaminoglycans Are Targeted by Bleomycin in Cancer Cells.

41. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.

42. Glycomics expression analysis of sulfated glycosaminoglycans of human colorectal cancer tissues and non-neoplastic mucosa by electrospray ionization mass spectrometry.

43. GAG-ID: Heparan Sulfate (HS) and Heparin Glycosaminoglycan High-Throughput Identification Software.

44. Breast cyst fluid heparan sulphate is distinctively N-sulphated depending on apocrine or flattened type.

45. Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.

46. Capillary electrophoretic analysis of isolated sulfated polysaccharides to characterize pharmaceutical products.

47. Mass spectrometric methods for the analysis of heparin and heparan sulfate.

48. Delivery of therapeutic protein for prevention of neurodegenerative changes: comparison of different CSF-delivery methods.

49. Composition, sequencing and ion mobility mass spectrometry of heparan sulfate-like octasaccharide isomers differing in glucuronic and iduronic acid content.

50. Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography-electrospray ionization-tandem mass spectrometry.

Catalog

Books, media, physical & digital resources